Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Moorfields launches preservative-free eye drops

Moorfields Pharmaceuticals is launching  preservative-free eye drops for the prevention and treatment of allergic conjunctivitis.Catacrom contains sodium cromoglicate in a single unit dose format. Moorfields says it has developed the product with a preservative-free formulation so that symptoms will not be exacerbated by preservatives, which are often used in multi-dose formats.The launch has been timed to coincide with the hayfever season, but the product can also be used to help people who suffer with perennial allergic conjunctivitis brought on by house dust mites, pet fur and allergic reactions from contact with substances such as cosmetics.The product is suitable as a prophylaxis, but treatment should be started before the patient is exposed to the allergen. It is suitable for use by children and users of gas permeable and rigid contact lenses.Price: Basic NHS cost £8.99 Moorfields PharmaceuticalsTel: 020 7684 9090

Topics

         
Registrant member of the Assurance and Appointments Committee 
Nationwide
£ Renumeration

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD012288

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel